Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6099259 | Journal of Crohn's and Colitis | 2014 | 6 Pages |
Abstract
Background and aims: Defects in the interleukin 10 (IL-10) signalling pathway have been shown to cause very early onset inflammatory bowel disease (IBD). We report a patient with severe infantile-onset IBD with a compound heterozygous IL-10 receptor alpha subunit (IL-10RA) mutation, one of which was paternally-inherited and the other occurring de novo. Methods: Deep sequencing of IL-10, IL-10RA and IL-10 receptor beta subunit (IL-10RB) were performed. Peripheral blood mononuclear cell (PBMC) surface expression of IL-10RA was analysed by flow cytometry. IL-10 signalling pathway was examined by measuring phosphorylated STAT3 in PBMC cultured in the presence of IL-6 or IL-10. Result: We identified a missense mutation in exon 4 of IL-10RA (c.583T>C) in one allele and a nonsense mutation in exon 7 of IL-10RA (c.1368G>T) in the other allele. Neither mutation has been reported previously. The patient has functional IL-10RA deficiency despite normal IL-10RA expression. Conclusion: This represents the first case report of a de novo mutation of IL-10RA that is associated with very early onset severe IBD. Therefore, IL-10 pathway defect should be considered in patients with infantile-onset IBD even if the parents are non-consanguineous.
Keywords
IL-10Very Early Onset Inflammatory Bowel DiseaseHSCTPCDAITPNTregpSTAT3STAT3NBTTNFαIBDPBMCLPSregulatory T-cellsInterleukin 10Inflammatory bowel diseasenitro blue tetrazoliumtumour necrosis factor alphaperipheral blood mononuclear cellsphosphorylated STAT3lipopolysaccharidesignal transducer and activator of transcription 3Genome-wide association studiesGWASpaediatrichaematopoietic stem cell transplantation
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Cheng Hiang Lee, Peter Hsu, Brigitte Nanan, Ralph Nanan, Melanie Wong, Kevin J. Gaskin, Rupert W. Leong, Ryan Murchie, Aleixo M. Muise, Michael O. Stormon,